Over the past few years, artificial intelligence (AI) has become increasingly popular in the world of finance. One area where it has particularly shown its prowess is in trading. AI-powered trading robots have become a valuable tool for investors and traders looking to make more informed decisions and increase their returns. One such AI trading robot that has been generating impressive returns for its clients is the Pair Trader.
The Pair Trader is a sophisticated algorithmic trading system that uses AI to identify profitable trades in the stock market. Its recent success in generating 18% for TMO over the past 3 months is a testament to its effectiveness. The Pair Trader's strategy involves identifying pairs of stocks that are highly correlated and then taking advantage of any divergence between them.
The Pair Trader has been particularly successful in the electric utilities, services, real estate, and precious metals sectors. These sectors are known for their stability and relatively predictable behavior, which makes them ideal for pair trading. The robot uses technical analysis (TA) to identify patterns and trends in the price movements of these stocks and then makes trading decisions based on this data.
The results speak for themselves. Over the past 3 months, TMO has seen an 18% return on investment from the Pair Trader's trading strategy. This is an impressive performance that has outperformed many other investment strategies in the same period.
The use of AI in trading is still a relatively new development, but it has already proven to be a powerful tool for investors and traders. The Pair Trader is just one example of how AI can be used to identify profitable trades in the stock market. As AI technology continues to evolve, we can expect to see more sophisticated and effective trading robots emerge, offering investors even greater returns on their investments.
In conclusion, the Pair Trader is an AI-powered trading robot that has been generating impressive returns for TMO in the electric utilities, services, real estate, and precious metals sectors. Its success over the past 3 months highlights the potential of AI in trading and is a clear indication of the benefits it can offer investors and traders.
TMO's Aroon Indicator triggered a bullish signal on February 10, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 325 similar instances where the Aroon Indicator showed a similar pattern. In of the 325 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The 10-day moving average for TMO crossed bullishly above the 50-day moving average on January 10, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TMO advanced for three days, in of 330 cases, the price rose further within the following month. The odds of a continued upward trend are .
TMO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The 10-day RSI Indicator for TMO moved out of overbought territory on January 31, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on February 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on TMO as a result. In of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for TMO turned negative on February 06, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .
TMO moved below its 50-day moving average on February 11, 2025 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TMO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. TMO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.713) is normal, around the industry mean (23.423). P/E Ratio (37.375) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (2.868) is also within normal values, averaging (5.667). Dividend Yield (0.002) settles around the average of (0.018) among similar stocks. P/S Ratio (5.227) is also within normal values, averaging (41.123).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of analytical and environment monitoring instruments
Industry MedicalSpecialties